A class action investigation has been launched against the Victoria state government and private contractors over alleged failures in the state’s hotel quarantine program believed to be responsible for its second wave of coronavirus cases.
Law firm Norton Rose Fulbright has warned of a serious risk of industry-wide class actions against the aged care sector over its handling of COVID-19, but if the largest plaintiffs law firms are planning litigation they are keeping their cards close to their chest.
An appeals court has been urged to uphold a judge’s $125 million penalty against Volkswagen in the ACCC’s case over the car maker’s emissions cheating, with a court-appointed contradictor saying the judge was “starved” of the information he required to assess whether a $75 million agreement brokered by the consumer watchdog was reasonable.
The majority shareholder in insurance broker Coverforce has won its bid to use documents from an existing lawsuit over the company’s $25 million acquisition of Suncorp unit Resilium in new proceedings it intends to bring.
Aged care operator Uniting has agreed to make $3.36 million in back payments to about 9,500 employees who were underpaid their full entitlements over a period of six years.
A judge has ordered that disputes arising between Transurban and a group of contractors over the discovery of toxic PFAS chemicals in the soil at the site of the multi-billion dollar West Gate Tunnel project in Melbourne be sent to arbitration.
A judge has slugged the Australia Workers’ Union with a $148,100 fine for artificially boosting member numbers in what he said was a “serious departure” from the record-keeping standards required by registered organisations under the Fair Work Act.
The makers of Bombay Sapphire gin have failed to stop an Australian company from trade marking their beer ‘Royal Bombay Premium Larger’.
An error in an opt out notice sent to motorists eligible to sign up for a class action over allegedly defective diesel filters in Toyota vehicles has left a class action law firm on the hook for indemnity costs to cover a new notice to group members.
A former QRx Pharma director’s prediction that shareholders would not receive “anything of consequence” from a class action settlement has proven true, with only a small slice of the $7 million settlement expected to go to shareholders.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
